Takumi Memida

Background/Objectives: Estrogen is a key female hormone; however, its role in periodontitis remains poorly understood. This study investigated the effects of 17β-estradiol (E2) on experimental periodontitis using an ovariectomy (OVX) model with E2 administration. Methods: Female mice aged 8–10 weeks underwent OVX, followed by induction of ligature-induced periodontitis, and subsequent quantification of alveolar bone resorption. Additional groups received an aromatase inhibitor or E2 supplementation after OVX, with subsequent induction of periodontitis and evaluation of bone resorption. Histological analysis assessed multinucleated giant cells and tartrate-resistant acid phosphatase-positive osteoclasts on the bone surface. Gingival tissue was analyzed for gene expression related to osteoclastogenesis. The effect of E2 on osteoclast differentiation from bone marrow cells was also examined. Results: OVX significantly reduced serum E2 levels and decreased alveolar bone resorption. Aromatase inhibitor administration similarly reduced bone loss. Histological evaluation revealed a reduced number of resorbing osteoclasts in OVX mice, whereas E2 supplementation increased osteoclast numbers. No significant changes in inflammatory cytokine or receptor activator of nuclear factor-kappa B ligand (RANKL) expression were observed. E2 promoted osteoclast differentiation in vitro, and treatment with E2 prior to RANKL stimulation further increased the number of osteoclasts. This effect was suppressed by an estrogen receptor antagonist. Moreover, E2 enhanced the expression of osteoclast differentiation–associated genes in the presence of RANKL, an effect abolished by tamoxifen. Conclusions: E2 increased alveolar bone resorption in experimental periodontitis, likely by promoting osteoclast differentiation, independent of inflammatory cytokine or RANKL gene expression.

Fluoride plays a dual role in dental health—preventing caries at optimal levels but causing fluorosis when excessive. While most animal studies focus on young mice, age-related susceptibility to fluoride remains poorly understood. This study presents the first comprehensive analysis of developmental stage–dependent differences in fluoride toxicity, focusing on enamel formation and systemic fluoride clearance. Male C57BL/6J mice—adolescent (5–9 weeks) and mature (16–20 weeks)—were exposed to fluoride in drinking water (0, 50, 100, or 125 ppm) for 6 weeks. Adolescent mice developed pronounced dental fluorosis, characterized by chalky white incisors, elevated Quantitative Light-induced Fluorescence (QLF) values, reduced enamel microhardness, and lower enamel mineral density (EMD). Histological analysis revealed disrupted ameloblast morphology, reduced KLK4 expression, and aprismatic enamel, with more severe effects in adolescents. In contrast, mature mice exhibited minimal changes in QLF, enamel hardness, and EMD. Systemic fluoride analysis showed significantly lower serum and urinary fluoride levels in adolescent mice compared to mature mice, indicating reduced excretion and increased tissue accumulation. These findings demonstrate that younger mice are more vulnerable to fluoride-induced enamel defects due to lower clearance than mature mice. This study provides critical evidence of age-related differences in fluoride toxicity, revealing heightened vulnerability during developmental stages. Our findings have significant public health implications, supporting the need for age-specific fluoride exposure guidelines to balance caries prevention and developmental fluoride toxicity.